ALLMedicine™ Zollinger-Ellison Syndrome Center
Research & Reviews 69 results
The American Journal of Gastroenterology; Bhattacharya S, Blau JE et. al.
Sep 14th, 2021 - Zollinger-Ellison syndrome (ZES) is characterized by gastrinoma-induced hypergastrinemia causing excessive gastric acid secretion. Secretin stimulation tests (SSTs) are required for diagnosis in the majority of patients. Two case reports suggest t...
BMJ Case Reports; Odisho T, Shi D et. al.
Aug 21st, 2021 - Three distinct gastric carcinoid (GC) tumour types have been described based on differing biological behaviour and prognoses. Type I GC tumours account for the vast majority (70%-80%), are associated with chronic atrophic gastritis and have a low ...
Pancreatology : Official Journal of the International Ass... Perrier M, Delemer B et. al.
Dec 15th, 2020 - We report here the first case of life-threatening hypomagnesemia in a Zollinger-Ellison syndrome patient with multiple endocrine neoplasia type 1 (MEN1) syndrome. The severe symptomatic hypomagnesemia proved to be due to proton pump inhibitors (PP...
European Heart Journal; Luiso D, Zuccarino F et. al.
Jul 18th, 2020 - Primary intracardiac gastrinoma causing Zollinger-Ellison syndrome.|2020|Luiso D,Zuccarino F,Tizón-Marcos H,Ble M,|
The American Surgeon; Freund MR, Reissman P et. al.
Feb 29th, 2020 - Jejunal Perforations in Zollinger-Ellison Syndrome: Expect the Unexpected.|2020|Freund MR,Reissman P,Schwarz AD,|etiology,etiology,etiology,complications,
Drugs 434 results see all →
News 18 results
Summary Company Announcement Date: January 07, 2020 FDA Publish Date: January 07, 2020 Product Type: Drugs Reason for Announcement: Recall Reason Description NDMA (Nitrosodimethylamine) impurity Company Name: Appco Pharma LLC Brand Name: Brand Nam...
Summary Company Announcement Date: December 19, 2017 FDA Publish Date: December 29, 2017 Product Type: Drugs Generic Drugs Reason for Announcement: Recall Reason Description Contains glass particles Company Name: AuroMedics Pharma LLC Brand Name: ...
Oct 25th, 2019 - My Take: It's Time for a Change. Do You Agree? The patient may not like it, but it's worth at least trying to taper his PPI at this time, with a goal of stopping regular PPI dosing altogether. Like many others, this patient is using his PPI as chr...
Summary Company Announcement Date: September 23, 2019 FDA Publish Date: September 23, 2019 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA) Compa...
May 22nd, 2019 - SAN DIEGO — Prescriptions for proton pump inhibitors (PPIs) have skyrocketed over the past 2 decades, along with concerns about inappropriate use and adverse events. Prescriptions for PPIs went from 1.6% of ambulatory care visits in 1998 to 7.6% i...